Causes of Hepatic Portal Vein Thrombosis

Local Risk Factors

Liver cirrhosis is the most common cause of portal vein thrombosis, accounting for over half of cases, especially in advanced liver disease with decreased portal flow velocity 1, 2
Malignancies, such as hepatocellular carcinoma, are present in 20-35% of HCC patients at diagnosis and can cause portal vein thrombosis 3
Focal inflammatory conditions, including pancreatitis, inflammatory bowel disease, diverticulitis, appendicitis, cholecystitis, and intra-abdominal infections, can increase the risk of portal vein thrombosis 4
Surgical and traumatic causes, such as splenectomy, abdominal surgery, liver transplantation, abdominal trauma, and surgical portosystemic shunting, can also contribute to the development of portal vein thrombosis 4, 2
Neonatal and pediatric specific factors, including omphalitis and umbilical vein catheterization, can increase the risk of portal vein thrombosis in this population 5, 6

Inherited thrombophilias, such as factor V Leiden mutation and prothrombin G20210A gene mutation, can increase the risk of portal vein thrombosis by 4-11 fold and 4-5 fold, respectively 7, 8
Acquired thrombophilias, including myeloproliferative neoplasms, antiphospholipid syndrome, and paroxysmal nocturnal hemoglobinuria, can also contribute to the development of portal vein thrombosis 7, 8
Hormonal factors, such as oral contraceptive use and pregnancy, can increase the risk of portal vein thrombosis 7, 8

In Western countries, myeloproliferative disorders and inherited thrombophilias are more common causes of portal vein thrombosis 5, 6
In Asian countries, there is a higher prevalence of Behçet's disease, inferior vena cava webs, and hydatid cysts, which can contribute to the development of portal vein thrombosis 5, 6

In 46% of patients with Budd-Chiari syndrome and 10% of patients with portal vein thrombosis, two or more prothrombotic factors are present 5, 6
In patients with a local risk factor, a prothrombotic factor is found in 36% of cases 5, 6
Over 60% of patients with inherited thrombophilia and portal vein thrombosis have an additional risk factor 5, 6

Decreased portal flow velocity, below 15 cm/s, is a significant risk factor for portal vein thrombosis development in cirrhotic patients 1, 2
Non-selective beta-blockers may increase the risk of portal vein thrombosis in cirrhotic patients, though this association may be confounded by the presence of more severe portal hypertension in these patients 1, 2
Obesity, metabolic syndrome, and NASH cirrhosis are emerging as independent risk factors for portal vein thrombosis 1, 2

PVT develops primarily due to portal hypertension and reduced portal blood flow, not hypercoagulability, in patients with severe liver disease 9, 10
The severity of liver disease is the most important modulator of PVT risk, with annual incidence ranging from 1.6% to 24.4% in cirrhotic patients 10
Severity of liver disease independently predicts both PVT (with thrombocytopenia and prior variceal bleeding as strongest predictors) and HRS development 9

PVT pathogenesis involves portal vein intimal hyperplasia and reduced portal flow, not systemic hemodynamic collapse, according to the Journal of Thrombosis and Haemostasis 9, 10
Anticoagulation-induced recanalization of PVT may reduce portal pressure, potentially improving portal hypertension-related complications 11
Recognize that thrombocytopenia predicts PVT development (HR 3.6) but also indicates advanced liver disease that predisposes to HRS, as reported by the Journal of Thrombosis and Haemostasis 9
Consider anticoagulation for PVT, which is safe and effective even in cirrhotic patients and does not increase bleeding risk, as stated by the Journal of Thrombosis and Haemostasis 11